About 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole
4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole (PubChem CID 141325581) has the molecular formula C27H14N16OS
and a molecular weight of 610.59 g/mol. Its IUPAC name is 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole.
Molecular Properties
| Compound Name | 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole |
| PubChem CID | 141325581 |
| Molecular Formula | C27H14N16OS |
| Molecular Weight | 610.59 g/mol |
| Exact Mass | 610.13 |
| IUPAC Name | 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole |
| SMILES | c1ccc(-c2nc3cc(-c4conn4)c(-c4csnn4)c(-c4c[nH]nn4)c3c(-c3cccc4[nH]nnc34)c2-c2nnn[nH]2)nc1 |
| InChI | InChI=1S/C27H14N16OS/c1-2-7-28-14(5-1)26-24(27-36-40-41-37-27)21(12-4-3-6-15-25(12)35-39-31-15)22-16(30-26)8-13(18-10-44-42-33-18)20(19-11-45-43-34-19)23(22)17-9-29-38-32-17/h1-11H,(H,29,32,38)(H,31,35,39)(H,36,37,40,41) |
| InChIKey | CVCNQUUGJOSTNC-UHFFFAOYSA-N |
| XLogP | 3.77 |
| TPSA | 228.08 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 610.59 |
| LogP ≤ 5 | 3.77 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
Analyze 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole?
The IUPAC name of 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole (CID 141325581) is 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole.
What is the SMILES notation for 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole?
The canonical SMILES for 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole is c1ccc(-c2nc3cc(-c4conn4)c(-c4csnn4)c(-c4c[nH]nn4)c3c(-c3cccc4[nH]nnc34)c2-c2nnn[nH]2)nc1.
What is the InChIKey of 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole?
The InChIKey is CVCNQUUGJOSTNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H14N16OS/c1-2-7-28-14(5-1)26-24(27-36-40-41-37-27)21(12-4-3-6-15-25(12)35-39-31-15)22-16(30-26)8-13(18-10-44-42-33-18)20(19-11-45-43-34-19)23(22)17-9-29-38-32-17/h1-11H,(H,29,32,38)(H,31,35,39)(H,36,37,40,41).
What are the key properties of 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole?
4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole has a molecular weight of 610.59 g/mol, XLogP of 3.77, 6 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(1H-benzotriazol-4-yl)-2-pyridin-2-yl-3-(1H-tetrazol-5-yl)-6-(thiadiazol-4-yl)-5-(1H-triazol-4-yl)quinolin-7-yl]oxadiazole is sourced from PubChem (CID 141325581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).